317 related articles for article (PubMed ID: 25915596)
1. Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of germline mutations in breast cancer genes: RECQL.
Bowden AR; Tischkowitz M
Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
[TBL] [Abstract][Full Text] [Related]
3. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
[TBL] [Abstract][Full Text] [Related]
4. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
[TBL] [Abstract][Full Text] [Related]
5. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
[TBL] [Abstract][Full Text] [Related]
7. RECQL: a new breast cancer susceptibility gene.
Banerjee T; Brosh RM
Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
[TBL] [Abstract][Full Text] [Related]
8. Germline RECQL mutations in high risk Chinese breast cancer patients.
Kwong A; Shin VY; Cheuk IWY; Chen J; Au CH; Ho DN; Chan TL; Ma ESK; Akbari MR; Narod SA
Breast Cancer Res Treat; 2016 Jun; 157(2):211-215. PubMed ID: 27125668
[TBL] [Abstract][Full Text] [Related]
9. RECQL: a DNA helicase in breast cancer.
Akbari MR; Cybulski C
Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
[No Abstract] [Full Text] [Related]
10. Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.
Suszynska M; Ratajska M; Galka-Marciniak P; Ryszkowska A; Wydra D; Debniak J; Jasiak A; Wasag B; Cybulski C; Kozlowski P
Cancer Prev Res (Phila); 2022 Mar; 15(3):151-160. PubMed ID: 34906988
[TBL] [Abstract][Full Text] [Related]
11. Mutations in RECQL are not associated with breast cancer risk in an Australian population.
Li N; Rowley SM; Goode DL; Amarasinghe KC; McInerny S; Devereux L; ; Wong-Brown MW; Lupat R; Lee JEA; Hughes S; Thompson ER; Zethoven M; Li J; Trainer AH; Gorringe KL; Scott RJ; James PA; Campbell IG
Nat Genet; 2018 Oct; 50(10):1346-1348. PubMed ID: 30224651
[No Abstract] [Full Text] [Related]
12. RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.
Tavera-Tapia A; de la Hoya M; Calvete O; Martin-Gimeno P; Fernández V; Macías JA; Alonso B; Pombo L; de Diego C; Alonso R; Pita G; Barroso A; Urioste M; Caldés T; Newman JA; Benítez J; Osorio A
Hum Mutat; 2019 May; 40(5):566-577. PubMed ID: 30817846
[TBL] [Abstract][Full Text] [Related]
13. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
15. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
[TBL] [Abstract][Full Text] [Related]
16. ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Renault AL; Lesueur F; Coulombe Y; Gobeil S; Soucy P; Hamdi Y; Desjardins S; Le Calvez-Kelm F; Vallée M; Voegele C; ; Hopper JL; Andrulis IL; Southey MC; John EM; Masson JY; Tavtigian SV; Simard J
PLoS One; 2016; 11(6):e0156820. PubMed ID: 27270457
[TBL] [Abstract][Full Text] [Related]
17. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
Thompson ER; Doyle MA; Ryland GL; Rowley SM; Choong DY; Tothill RW; Thorne H; ; Barnes DR; Li J; Ellul J; Philip GK; Antill YC; James PA; Trainer AH; Mitchell G; Campbell IG
PLoS Genet; 2012 Sep; 8(9):e1002894. PubMed ID: 23028338
[TBL] [Abstract][Full Text] [Related]
19. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Mantere T; Tervasmäki A; Nurmi A; Rapakko K; Kauppila S; Tang J; Schleutker J; Kallioniemi A; Hartikainen JM; Mannermaa A; Nieminen P; Hanhisalo R; Lehto S; Suvanto M; Grip M; Jukkola-Vuorinen A; Tengström M; Auvinen P; Kvist A; Borg Å; Blomqvist C; Aittomäki K; Greenberg RA; Winqvist R; Nevanlinna H; Pylkäs K
Sci Rep; 2017 Apr; 7(1):681. PubMed ID: 28386063
[TBL] [Abstract][Full Text] [Related]
20. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'.
Ahmed H; Lerner-Ellis J; Cybulski C; Metcalfe K; Lubiński J; Narod SA; Akbari MR
Nat Genet; 2018 Oct; 50(10):1348-1349. PubMed ID: 30224648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
